JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 8 1454-1457
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houston, T. K.
Right arrow Articles by Cowan, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houston, T. K., II
Right arrow Articles by Cowan, R. J.

Gallium-67-Citrate Scanning of Renal Parenchymal Malacoplakia

Thomas K. Houston, II, James E. Peacock, Jr., Richard G. Appel and Robert J. Cowan

Department of Internal Medicine, Sections on Infectious Diseases and Nephrology and Department of Radiology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina

Correspondence: For correspondence contact: James E. Peacock, Jr., MD, Department of Internal Medicine, Section on Infectious Diseases, Bowman Gray School of Medicine, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC 27157.

ABSTRACT

The purpose of this article is to review the potential role of nuclear medicine scanning, especially with 67Ga,in the presumptive diagnosis and clinical management of patients with renal parenchymal malacoplakia (RPMP), a rare disease associated with coliform bacterial infection of the kidney and characterized by chronic unresolving inflammatory infiltrates containing von Hansemann macrophages in the renal parenchyma. Methods: Published cases of RPMP were collected from the archival literature by searching the MEDLINE database and by reviewing bibliographic references contained in articles on malacoplakia. Data on the clinical features and radiographic evaluation of patients with RPMP were extracted from the clinical case reports. Results: Forty-three cases of RPMP published over the past 20 yr were identified. Ten of the 43 patients (23%) had 67Ga scanning as a component of their diagnostic evaluation. In all 10 patients, renal uptake of 67Ga was classified as intense. Two of those 10 patients had serial 67Ga scanning performed to assess response to antibiotic treatment; both patients exhibited decreased uptake or complete resolution of abnormal renal uptake over time, a finding also exhibited by our patient. Conclusion: Intense renal uptake of 67Ga, typically in the clinical setting of fever, progressive renal failure and nephromegaly, strongly supports a diagnosis of RPMP. In those patients receiving pro longed antimicrobial therapy for RPMP, resolution of abnormal 67Ga uptake over time may provide an objective endpoint for treatment.

Key Words: malacoplakia • nephromegaly • gallium-67 scanning • acute renal failure




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
R. Dharmadhikari and A. Crisp
Sequential changes in sonographic appearances of childhood renal malakoplakia progressing to end-stage renal failure.
J. Ultrasound Med., September 1, 2006; 25(9): 1219 - 1222.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J.-J. Hong, P.-L. Liao, J.-L. Lin, S. Hsueh, and C.-C. Huang
Bilateral renal parenchymal malakoplakia presenting as haemolytic–uraemic syndrome
Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2206 - 2209.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.